Impact of the Ottawa model on opiate screening and smoking cessation in methadone-treated patients with opioid use disorder: A retrospective cohort analysis
Introduction Approximately 60 million individuals worldwide used opioids in 2021, constituting 1.2% of the global adult population. This study aimed to evaluate the effectiveness of integrated treatment strategies for opioid use disorder and nicotine use disorder by assessing the impact of smoking c...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
European Publishing
2024-07-01
|
| Series: | Tobacco Induced Diseases |
| Subjects: | |
| Online Access: | https://www.tobaccoinduceddiseases.org/Impact-of-the-Ottawa-model-on-opiate-screening-and-smoking-cessation-in-methadone,191247,0,2.html |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832587214144405504 |
|---|---|
| author | Shu-Wua Lee Po-Chung Yu Ting-Ting Yen Chiann-Yi Hsu Li-Jou Lai I-Chun Chen Ting-Gang Chang |
| author_facet | Shu-Wua Lee Po-Chung Yu Ting-Ting Yen Chiann-Yi Hsu Li-Jou Lai I-Chun Chen Ting-Gang Chang |
| author_sort | Shu-Wua Lee |
| collection | DOAJ |
| description | Introduction
Approximately 60 million individuals worldwide used opioids in 2021,
constituting 1.2% of the global adult population. This study aimed to evaluate
the effectiveness of integrated treatment strategies for opioid use disorder and
nicotine use disorder by assessing the impact of smoking cessation within a
methadone treatment framework.
Methods
In a retrospective cohort study, 53 methadone maintenance patients were
divided into 16 treatment-seeking smokers (TSS) and 37 treatment-rejecting
smokers (TRS) based on their participation in the Ottawa model for smoking
cessation plus 16 weeks of varenicline treatment. Both groups received standard
methadone treatment for 68 weeks. TSS were followed up for 44 weeks to assess
smoking cessation outcomes, while TRS had none due to their lack of participation
in smoking cessation treatment.
Results
The median age of the TSS group was 48 years, while that of the TRS group
was 45.5 years. Males comprised 75% of TSS and 94.6% of the TRS. TSS exhibited
an 83% decrease in positive opioid screen results compared to TRS (p=0.023).
In TSS, peak smoking cessation success was observed at week 20, with 57% of
participants maintaining carbon monoxide levels <5 ppm.
Conclusions
The significant reduction in positive opioid screens and the high
smoking cessation rate in the TSS group highlight the efficacy of combined
treatment methods. This study underscores the advantages of integrating smoking
cessation with methadone maintenance treatment, indicating that comprehensive
approaches can substantially improve treatment outcomes. |
| format | Article |
| id | doaj-art-57f937eb009c4d24a1ba9ae9635c33b4 |
| institution | Kabale University |
| issn | 1617-9625 |
| language | English |
| publishDate | 2024-07-01 |
| publisher | European Publishing |
| record_format | Article |
| series | Tobacco Induced Diseases |
| spelling | doaj-art-57f937eb009c4d24a1ba9ae9635c33b42025-01-24T15:27:00ZengEuropean PublishingTobacco Induced Diseases1617-96252024-07-0122July11210.18332/tid/191247191247Impact of the Ottawa model on opiate screening and smoking cessation in methadone-treated patients with opioid use disorder: A retrospective cohort analysisShu-Wua Lee0Po-Chung Yu1Ting-Ting Yen2Chiann-Yi Hsu3Li-Jou Lai4I-Chun Chen5Ting-Gang Chang6https://orcid.org/0000-0001-9156-7413Department of Psychiatry, Taichung Veterans General Hospital, Taichung, TaiwanDepartment of Psychiatry, Taichung Veterans General Hospital, Taichung, TaiwanDepartment of Otorhinolaryngology, Taichung Veterans General Hospital, Taichung, TaiwanBiostatistics Task Force, Taichung Veterans General Hospital, Taichung, TaiwanDepartment of Psychiatry, Taichung Veterans General Hospital, Taichung, TaiwanDepartment of Psychiatry, Taichung Veterans General Hospital, Taichung, TaiwanDepartment of Psychiatry, Taichung Veterans General Hospital, Taichung, TaiwanIntroduction Approximately 60 million individuals worldwide used opioids in 2021, constituting 1.2% of the global adult population. This study aimed to evaluate the effectiveness of integrated treatment strategies for opioid use disorder and nicotine use disorder by assessing the impact of smoking cessation within a methadone treatment framework. Methods In a retrospective cohort study, 53 methadone maintenance patients were divided into 16 treatment-seeking smokers (TSS) and 37 treatment-rejecting smokers (TRS) based on their participation in the Ottawa model for smoking cessation plus 16 weeks of varenicline treatment. Both groups received standard methadone treatment for 68 weeks. TSS were followed up for 44 weeks to assess smoking cessation outcomes, while TRS had none due to their lack of participation in smoking cessation treatment. Results The median age of the TSS group was 48 years, while that of the TRS group was 45.5 years. Males comprised 75% of TSS and 94.6% of the TRS. TSS exhibited an 83% decrease in positive opioid screen results compared to TRS (p=0.023). In TSS, peak smoking cessation success was observed at week 20, with 57% of participants maintaining carbon monoxide levels <5 ppm. Conclusions The significant reduction in positive opioid screens and the high smoking cessation rate in the TSS group highlight the efficacy of combined treatment methods. This study underscores the advantages of integrating smoking cessation with methadone maintenance treatment, indicating that comprehensive approaches can substantially improve treatment outcomes.https://www.tobaccoinduceddiseases.org/Impact-of-the-Ottawa-model-on-opiate-screening-and-smoking-cessation-in-methadone,191247,0,2.htmlsmoking cessationmethadone maintenance treatmentottawa model for smoking cessationurine drug testopioid use disorder |
| spellingShingle | Shu-Wua Lee Po-Chung Yu Ting-Ting Yen Chiann-Yi Hsu Li-Jou Lai I-Chun Chen Ting-Gang Chang Impact of the Ottawa model on opiate screening and smoking cessation in methadone-treated patients with opioid use disorder: A retrospective cohort analysis Tobacco Induced Diseases smoking cessation methadone maintenance treatment ottawa model for smoking cessation urine drug test opioid use disorder |
| title | Impact of the Ottawa model on opiate screening and smoking cessation in methadone-treated patients with opioid use disorder: A retrospective cohort analysis |
| title_full | Impact of the Ottawa model on opiate screening and smoking cessation in methadone-treated patients with opioid use disorder: A retrospective cohort analysis |
| title_fullStr | Impact of the Ottawa model on opiate screening and smoking cessation in methadone-treated patients with opioid use disorder: A retrospective cohort analysis |
| title_full_unstemmed | Impact of the Ottawa model on opiate screening and smoking cessation in methadone-treated patients with opioid use disorder: A retrospective cohort analysis |
| title_short | Impact of the Ottawa model on opiate screening and smoking cessation in methadone-treated patients with opioid use disorder: A retrospective cohort analysis |
| title_sort | impact of the ottawa model on opiate screening and smoking cessation in methadone treated patients with opioid use disorder a retrospective cohort analysis |
| topic | smoking cessation methadone maintenance treatment ottawa model for smoking cessation urine drug test opioid use disorder |
| url | https://www.tobaccoinduceddiseases.org/Impact-of-the-Ottawa-model-on-opiate-screening-and-smoking-cessation-in-methadone,191247,0,2.html |
| work_keys_str_mv | AT shuwualee impactoftheottawamodelonopiatescreeningandsmokingcessationinmethadonetreatedpatientswithopioidusedisorderaretrospectivecohortanalysis AT pochungyu impactoftheottawamodelonopiatescreeningandsmokingcessationinmethadonetreatedpatientswithopioidusedisorderaretrospectivecohortanalysis AT tingtingyen impactoftheottawamodelonopiatescreeningandsmokingcessationinmethadonetreatedpatientswithopioidusedisorderaretrospectivecohortanalysis AT chiannyihsu impactoftheottawamodelonopiatescreeningandsmokingcessationinmethadonetreatedpatientswithopioidusedisorderaretrospectivecohortanalysis AT lijoulai impactoftheottawamodelonopiatescreeningandsmokingcessationinmethadonetreatedpatientswithopioidusedisorderaretrospectivecohortanalysis AT ichunchen impactoftheottawamodelonopiatescreeningandsmokingcessationinmethadonetreatedpatientswithopioidusedisorderaretrospectivecohortanalysis AT tinggangchang impactoftheottawamodelonopiatescreeningandsmokingcessationinmethadonetreatedpatientswithopioidusedisorderaretrospectivecohortanalysis |